Cat Allergy Shots for Humans: FDA-Standardized SCIT Guide
Cat allergy shots are subcutaneous immunotherapy (SCIT) for HUMANS allergic to cat dander — not veterinary products. Cat-hair and cat-pelt extracts are the only FDA-standardized mammalian extracts in the US (Greer license #308, 10,000 BAU/mL), and Alvarez-Cuesta 1994 JACI and Varney 1997 Clin Exp Allergy document ~72% symptom reduction. Treatment spans 3–5 years.
8 peer-reviewed sources
Cat allergy shots are SCIT for humans sensitized to cat dander. FDA-standardized Fel d 1 extract yields approximately 72% symptom reduction in controlled RCTs. Treatment requires 3–5 years.
The essentials
Cat allergy shots are subcutaneous immunotherapy (SCIT) given to HUMANS allergic to cat dander — not a veterinary product for cats with allergies. If you searched 'cat allergy shots' because your cat itches or has skin problems, that is feline atopic dermatitis, managed by a veterinarian with topical therapy or veterinary allergen-specific immunotherapy injected into the cat itself. This page covers human immunotherapy for cat-dander sensitization.
For human patients, cat is the flagship of pet-allergen immunotherapy and the only mammalian allergen category with FDA-standardized extracts in the US. Cat-hair and cat-pelt, both at 10,000 BAU/mL under Greer license #308, are standardized by the FDA's Center for Biologics Evaluation and Research (CBER). This standardization means a 1,000-BAU maintenance dose in Seattle is biochemically equivalent to a 1,000-BAU maintenance dose in Miami — a consistency that is NOT available for dog, horse, or any other mammalian extract.
Fel d 1, a 35–38 kDa tetrameric secretoglobin produced in sebaceous, salivary, anal, and lacrimal glands, sensitizes 90–96% of cat-allergic patients and accounts for 60–90% of total IgE reactivity to cat dander (Grönlund H et al., Int Arch Allergy Immunol 2010). Intact male cats produce 3–5 times more Fel d 1 than neutered males due to testosterone regulation (Kelly SM et al., JACI 2018: median urinary Fel d 1 5.15 µg/mL intact vs 0.013 µg/mL neutered). Notably, hairless Sphynx cats still produce Fel d 1 (Hilger C et al., PMC10975736, 2024) — no cat breed is genuinely hypoallergenic.
Fel d 1 particles are unusually persistent: Wood RA et al. (JACI 1989) found levels remained elevated in cat-removed homes for 20+ weeks. NHANES 2005–2006 detected Fel d 1 in 99.9% of US homes including cat-free homes (Salo PM et al., JACI 2014;134:350–359). This persistence makes avoidance alone impractical and strengthens the case for immunotherapy.
A diagnostically important molecular point: a patient presenting with apparent cat allergy may actually be primarily sensitized to horse or dog via Fel d 4 ↔ Equ c 1 ↔ Can f 6 cross-reactivity. Fel d 4 shares ~67% sequence identity with horse Equ c 1 and dog Can f 6. Curex pairs at-home IgE component testing with board-certified allergist review to distinguish primary Fel d 1 sensitization (cat-specific secretoglobin) from Fel d 4 lipocalin sensitization that cross-reacts with horse and dog — clinically meaningful because the immunotherapy plan changes entirely if the primary driver is not actually the cat.
The standard SCIT regimen follows Cox L et al., JACI 2011 PP3: weekly injections over approximately 26 weeks during build-up, then every 2–4 weeks for 3–5 years of maintenance. A 30-minute post-injection observation period is required at every visit per AAAAI/ACAAI standard of care.
How allergy shots retrain your immune system
Cat allergy shots work by gradually exposing your immune system to escalating doses of Fel d 1, shifting the response from an IgE-driven allergic cascade toward immune tolerance. During build-up, allergen-specific IgG4 blocking antibodies rise 10- to 100-fold, competitively binding Fel d 1 particles before they can cross-link IgE on mast cells. Over years of maintenance, allergen-specific regulatory T cells expand, IL-10 and TGF-beta are secreted, and Th2 cytokines driving inflammation — IL-4, IL-5, IL-13 — decline. This remodeling persists after the treatment course ends.
Component-Resolved Diagnosis
A board-certified allergist confirms IgE-mediated sensitization to Fel d 1 via skin prick test or serum IgE assay, ruling out lipocalin cross-reactivity (Fel d 4, Fel d 7) from horse or dog as the primary driver. This step determines whether cat SCIT is the appropriate treatment.
Build-Up Phase (weekly, ~26 weeks)
Injections start at a dose roughly 1,000–10,000 times below the eventual maintenance level and increase stepwise. A 30-minute post-injection observation period is mandatory at every visit per AAAAI/ACAAI standard of care, as approximately 85% of systemic reactions occur within this window.
Maintenance Phase (every 2–4 weeks, 3–5 years)
Once the therapeutic maintenance dose (1,000–4,000 BAU per Cox 2011 PP3) is reached and tolerated, injections shift to every 2–4 weeks. Consistent dosing is essential — gaps longer than 5 weeks typically require dose reductions.
Durable Post-Treatment Remission
Durham SR et al. (NEJM 1999;341:468–475) demonstrated that 3 years of SCIT yields at least 4 years of sustained remission after discontinuation. A complete 3-to-5-year course is estimated to produce 7–12 years of post-treatment benefit.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Treatment timeline — phase by phase
Cat SCIT follows the three-phase structure of all subcutaneous allergen immunotherapy. Reaching the therapeutic maintenance dose and sustaining it long enough to produce durable benefit requires a 3-to-5-year commitment. Most patients begin to notice meaningful symptom improvement within 6–12 months of reaching maintenance.
Injections begin at a fraction of the therapeutic dose and increase stepwise over approximately 26 weekly visits. A 30-minute post-injection observation period is mandatory at every visit per Cox 2011 PP3 and AAAAI position statement.
Once the 1,000–4,000 BAU maintenance dose is reached and tolerated, the interval extends to every 2–4 weeks. Year 1 totals approximately 39 in-clinic visits; Years 2–5 require approximately 14–20 visits/year. The minimum recommended course for durable disease modification is 3 years per AAAAI/ACAAI Practice Parameter Third Update (Cox 2011).
After a complete 3-to-5-year course, the immune remodeling persists. Durham 1999 NEJM documented at least 4-year remission after 3 years of SCIT, and Eng et al. (Allergy 2006) reported sustained benefit 12 years after stopping childhood grass SCIT.
Efficacy by allergen — what the data shows
Cat SCIT has the strongest RCT evidence base of any pet-allergen immunotherapy, anchored by two rigorous double-blind placebo-controlled trials. The FDA-standardized extract enables allergists to reliably target the therapeutic maintenance dose, distinguishing cat from dog SCIT where lot-to-lot variability complicates dosing.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youTreatment options side by side
Cat-allergic patients have three main disease-modifying options — SCIT, now available either in-office or as an at-home allergy shot kit; sublingual immunotherapy (SLIT) drops, a needle-free modality (no cat-specific FDA-approved tablet currently exists, so drops are off-label); and symptomatic pharmacotherapy (antihistamines, nasal steroids), which provides relief without modifying the underlying allergy.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
At-Home Cat SCIT (Curex) | |||||
SLIT Drops (needle-free, cat-specific) | |||||
Antihistamines + Nasal Steroids |
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
Curex delivers cat SCIT as an at-home allergy shot kit for $129/month all-inclusive — the same FDA-standardized Fel d 1 immunotherapy behind the ~72% RCT data, given as one weekly self-administered shot that removes the clinic-injection burden driving nearly one in four conventional cat-SCIT patients to abandon treatment after the first visit per Tkacz 2021. The serum is sterile-compounded to USP <797>, a board-certified allergist oversees the plan, your first dose and every dose change are supervised live over Zoom, and a prescribed epinephrine auto-injector is confirmed on hand.
See if at-home shots are right for youSide effects — what to watch for
Cat SCIT shares the safety profile of all subcutaneous allergen immunotherapy. The vast majority of reactions are local and self-limited. Systemic reactions affecting areas beyond the injection arm are much rarer but are why a 30-minute post-injection observation period is required at every clinic visit.
Insurance coverage — what to expect
Cat SCIT is covered by all major US commercial insurers and Medicare Part B when standard medical necessity criteria are met. UnitedHealthcare ended coverage of home-administered SCIT effective January 1, 2023 — in-office administration with a 30-minute observation period is required. State-level Medicaid acceptance varies from 13.4% (New York) to 72.3% (California) per Ho FO et al., Am J Manag Care 2024. For full insurer-by-insurer coverage details, see /allergy-shots/cost/does-insurance-cover-allergy-shots.
Skip the insurance hassle — Curex is $129/mo flat, no insurance needed.
Start free assessmentFrequently asked questions
Are cat allergy shots for treating my cat or for treating me?
Cat allergy shots (SCIT) are for treating HUMANS who are allergic to cat dander — not for treating the cat. If your cat has itchy skin or allergic reactions of its own, that is feline atopic dermatitis, which a veterinarian treats with topical therapy, antihistamines, or sometimes veterinary allergen-specific immunotherapy injected into the cat. The human SCIT uses FDA-standardized cat-hair or cat-pelt extract (Greer license #308, 10,000 BAU/mL) administered by a board-certified allergist. Veterinary products like Cytopoint (Zoetis lokivetmab, for dogs' canine atopic dermatitis) and Apoquel (Zoetis oclacitinib, for dogs) are not human treatments and do not address your IgE sensitization to cat dander.
How effective are cat allergy shots?
Cat allergy shots are among the most effective available for any pet allergen. Varney VA et al. (Clin Exp Allergy 1997;27:860–867, DBPC, 28 patients) found symptom scores fell approximately 72% on simulated natural cat-room challenge in the active group, while placebo showed no change. Alvarez-Cuesta E et al. (JACI 1994;93:556–566) confirmed significant improvements in symptom-medication scores and bronchial provocation in a separate double-blind RCT. Cat is the only mammalian allergen with FDA-standardized extracts (both cat-hair and cat-pelt at 10,000 BAU/mL), which enables allergists to target and maintain the therapeutic Fel d 1 dose with greater consistency than unstandardized dog or horse extracts.
Does a hypoallergenic cat breed reduce the need for allergy shots?
No. While some breeds are marketed as hypoallergenic, all domestic cat breeds produce Fel d 1. Hilger C et al. (PMC10975736, 2024) confirmed that even hairless Sphynx cats — the most commonly cited hypoallergenic breed — produce Fel d 1. Intact male cats produce 3–5 times more Fel d 1 than neutered males (Kelly SM et al., JACI 2018), so neutering may modestly reduce allergen load. Fel d 1 is detected in 99.9% of US homes including cat-free homes (Salo PM et al., NHANES 2014), meaning even rehoming the cat does not eliminate allergen exposure on a useful timescale (Wood 1989 JACI: 20+ weeks to reach control levels). These realities are why immunotherapy remains the primary disease-modifying option.
How long do cat allergy shots take to work?
Most patients notice meaningful symptom improvement within 6–12 months of reaching the maintenance dose, typically 12–18 months after starting treatment. The AAAAI/ACAAI Practice Parameter Third Update (Cox 2011) states that clinical improvement is usually observed within one year of reaching maintenance. Full disease-modifying benefit — the kind that persists years after stopping — requires the minimum recommended 3-year course. Durham SR et al. (NEJM 1999;341:468–475) documented at least 4 years of sustained remission following a 3-year SCIT course. If no improvement is evident after one year of adequate maintenance, the allergist should reassess allergen selection and dosing.
What is Fel d 1 and why does it matter for allergy shots?
Fel d 1 is a 35–38 kDa tetrameric secretoglobin — the major cat allergen — produced in sebaceous, salivary, anal, and lacrimal glands. It sensitizes 90–96% of cat-allergic patients and accounts for 60–90% of total IgE reactivity to cat dander (Grönlund H et al., Int Arch Allergy Immunol 2010). For allergy shots, Fel d 1 is the target allergen in FDA-standardized cat-hair and cat-pelt extracts. The therapeutic target is approximately 1,000–4,000 BAU per injection (containing ~11–17 µg Fel d 1) per Cox 2011 PP3. Because the extract is FDA-standardized, allergists can reliably reach and sustain this dose — unlike unstandardized pet allergens where lot-to-lot variability makes therapeutic dosing less predictable.
Can I do cat allergy shots at home?
Conventional cat SCIT has historically been given in-office with a 30-minute post-injection observation period at a facility equipped to treat anaphylaxis, and the Cox 2011 AAAAI/ACAAI Practice Parameter cautioned against unsupervised self-administration; UnitedHealthcare also ended coverage of home-administered SCIT effective January 1, 2023. Those concerns were about doing shots at home without safeguards. Curex makes at-home cat SCIT possible for eligible maintenance patients by adding a specific safeguard stack: a serum sterile-compounded to USP <797>, a prescribed epinephrine auto-injector confirmed on hand before the first injection, the first dose and every dose change supervised live over Zoom by the prescribing allergist, gradual dose escalation, and ongoing allergist oversight. Sublingual immunotherapy (SLIT) drops remain a separate needle-free at-home modality, with cat-specific DBPC RCT support from Alvarez-Cuesta 2007 Allergy (59% symptom reduction vs placebo).
What are the risks of cat allergy shots?
Cat SCIT shares the safety profile of all subcutaneous allergen immunotherapy. Local injection-site reactions (redness, swelling, itching) occur in approximately 30–80% of patients and are considered normal. Large local reactions (palm-sized or larger) affect roughly 0.4% of injections and may prompt dose adjustment. Systemic reactions affecting areas beyond the injection arm occur in approximately 0.1–0.2% of injection visits (Epstein TG et al., Ann Allergy Asthma Immunol 2014). Fatal reactions are extremely rare: one fatality per 23.3M injection visits in US surveillance. The mandatory 30-minute observation period captures approximately 85% of all systemic reactions, which is why in-office administration is required. If you experience throat tightness, difficulty breathing, generalized hives, or lightheadedness after an injection, call 911 immediately and use an epinephrine auto-injector if available.
How do I know if I am sensitized to Fel d 1 specifically?
Component-resolved IgE testing identifies sensitization to specific molecular components — Fel d 1 (cat-specific secretoglobin), Fel d 2 (serum albumin), Fel d 4 (lipocalin), and Fel d 7 (lipocalin) — rather than just total cat extract IgE. This distinction matters clinically: Fel d 4 and Fel d 7 are lipocalins that cross-react with horse Equ c 1 (67% sequence identity) and dog Can f 6 (67% identity). A patient with high Fel d 4 IgE and low Fel d 1 IgE may actually be primarily sensitized to horse, making horse SCIT more appropriate than cat SCIT. A board-certified allergist interprets component testing results in the context of your clinical history to determine which allergen(s) should anchor your immunotherapy plan.
Related Articles
Allergy Shots for Dog Allergy | Curex Component-First Guide
Allergy shots for dog allergy treat HUMANS. Before you start, test Can f 1 vs Can f 5 — 16.5% can skip shots entirely. Dog SCIT evidence is 'poor and conflicting' (Smith 2016).
Read moreNames of Allergy Shots for Adults | Curex Guide
The clinical name is SCIT. Extracts come from Greer, ALK-Abelló, or Stallergenes Greer. FDA-approved branded tablets: Grastek, Oralair, Ragwitek, Odactra.
Read moreCat Allergy Vaccine Explained | Curex SCIT Guide
Cat allergy vaccine means three different things. SCIT uses FDA-standardized Fel d 1 extract for ~72% symptom relief. No one-shot cure exists.
Read moreAllergy Shots for Cat Allergy | Full SCIT Guide | Curex
Allergy shots for cat allergies reduce symptoms 60-72% at the 15 mcg Fel d 1 maintenance dose. Cat SCIT efficacy, dosing, and alternatives.
Read moreAllergy Shot for Dog Allergies | Curex Human SCIT Guide
Yes, there is an allergy shot for humans allergic to dogs — but dog SCIT evidence is 'poor and conflicting.' 16.5% of patients may skip shots if Can f 5-monosensitized.
Read moreDesensitization Allergy: SCIT Guide & Mechanism | Curex
Desensitization for allergy means SCIT — a 3-to-5-year dose-escalation course inducing immune tolerance. Cochrane 51 RCTs: SMD -0.73. Distinct from acute drug desensitization.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.